Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,351
datasets available to search
ShareScore release 0.9.0
Dataset results
1,351 results for “Intermediates”
CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
ClinicalTrials.gov study NCT00643617. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Prospective Study of Fractional Flow Reserve Assessment of Intermediate Coronary Stenoses in Severe Aortic Stenosis
ClinicalTrials.gov study NCT03442400. IPD Sharing: NO. Countries: 1. Publications: 0.
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS
ClinicalTrials.gov study NCT00439673. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
ClinicalTrials.gov study NCT06397703. IPD Sharing: NO. Countries: 1. Publications: 0.
An Efficacy and Safety Study of Luspatercept (ACE-536) for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in Japanese Subjects Who Are Not Req
ClinicalTrials.gov study NCT03900715. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer
ClinicalTrials.gov study NCT05169970. IPD Sharing: YES. Countries: 1. Publications: 0.
Intermediate Vision in Patients With Clareon IOLs Compared to Eyhance IOLs
ClinicalTrials.gov study NCT05226884. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy of Gemcitabine Submucosal Injection for Preventing Recurrence in Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Randomized Trial
ClinicalTrials.gov study NCT07198451. IPD Sharing: YES. Countries: 0. Publications: 12.
HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for "Intermediate Risk" HPV-16-associated Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04369937. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase II/III Trial Comparing Transarterial Tirapazamine Embolization (TATE) With cTACE for Intermediate-stage Liver Cancer.
ClinicalTrials.gov study NCT06844357. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Comparing Siltuximab Plus Best Supportive Care to Placebo Plus Best Supportive Care in Anemic Patients With International Prognostic Scoring System Low- or Intermediate-1-Risk Myelodysplastic
ClinicalTrials.gov study NCT01513317. IPD Sharing: Not stated. Countries: 7. Publications: 0.
An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Intermediate Age-Related Macular Degeneration
ClinicalTrials.gov study NCT02848313. IPD Sharing: NO. Countries: 1. Publications: 0.
Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN
ClinicalTrials.gov study NCT03529422. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rabbit Anti-thymocyte Globulin in the Treatment of Patients With Low to Intermediate-1 Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00542828. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Study to Separately Evaluate the Activity of Talacotuzumab (JNJ-56022473) or Daratumumab in Transfusion-Dependent Participants With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) Who Are R
ClinicalTrials.gov study NCT03011034. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Diet and Exercise Program to Promote Weight Loss and Improve Health in Men With Low- or Low-Intermediate-Risk Prostate Cancer
ClinicalTrials.gov study NCT02454517. IPD Sharing: Not stated. Countries: 1. Publications: 0.
18F-DCFPyL Positron Emission Tomography (PET) in Intermediate or High Risk Prostate Cancer
ClinicalTrials.gov study NCT04727736. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Oral Decitabine/Cedazuridine in Combination With Magrolimab in Participants With Intermediate- to Very High-Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT05835011. IPD Sharing: NO. Countries: 1. Publications: 0.
Data from: Pollination benefits are maximized at intermediate nutrient levels
Open the record for dataset details and reuse information.
Data from: Paraneoplastic neuronal intermediate filament autoimmunity
Open the record for dataset details and reuse information.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.